News

Time Between Lucentis and Eylea Treatments Found To Be Similar

The principal difference between the two leading FDA-approved anti-VEGF drugs, Eylea and Lucentis for treatment of retinal hemorrhage has been accepted as the difference in length of time between injections. A new study, however, found no significant difference in injection scheduling between the drugs. The overall mean days between injections differed by only 1.8 days [Read More]

Low Vision Seniors Are Self-Limiting Their Driving

A new cross-sectional study has concluded that most patients with AMD-related central vision loss continue to drive, but that they demonstrate significant driving restrictions, especially with more severe visual acuity and contrast sensitivity loss. To determine if central visual loss is associated with driving cessation, driving restriction, or other-driver preference, researchers compared two groups of [Read More]

Unequal Vision Can Cause Falling

New research reported in Optometry & Vision Science has shed light on the possibility that falling may be partially blamed on a common condition in older adults called anisometropia. Anisometropia is a condition in which a person’s eyes have unequal refractive power, meaning different levels of myopia (nearsightedness) or hyperopia (farsightedness). After assessing refractive error [Read More]